Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 47 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 8349894

    Compositions comprising an o/w emulsion containing conjugated linoleic acid

    Aker Biomarine AS · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  2. US 8344126

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  3. US 8343737

    Cell culture compositions capable of producing a VEGF-binding fusion polypeptide

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  4. US 8334313

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  5. US 8334273

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  6. CA 2838876

    COMPOSITIONS ET PROCEDES DE TRAITEMENT, DE SUPPRESSION, DE REDUCTION OU D'AMELIORATION D'UNE DOULEUR INFLAMMATOIRE

    BAUSCH & LOMB [US] · Granted Dec 13, 2012 · Expires Dec 8, 2032

    granted

  7. US 8324368

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Alnylam Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  8. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  9. US 8318693

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  10. US 8318177

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  11. US 8304397

    Identification of a micro-RNA that activates expression of β-myosin heavy chain

    The Board of Regents of the University of Texas System · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  12. US 8298532

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  13. US 8293707

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity

    Syntonix Pharmaceuticals, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  14. US 8288525

    Compositions and methods for inhibiting expression of CD45 gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  15. US 8283308

    Copolymer-stabilized emulsions

    The Regents of the University of California · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  16. US 8283461

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Benitec, Inc. · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  17. US 8277831

    Drug-enhanced adhesion prevention

    Advanced Technologies and Regenerative Medicine, LLC · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  18. US 8273870

    Compositions and methods for inhibiting expression of a mutant gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  19. US 8273867

    Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS

    The Regents of the University of California · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  20. US 8268618

    Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  21. US 8268799

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  22. US 8268615

    Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide

    The United States of America as represented by the Secretary of the Army · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  23. US 8268890

    Method of treating ischemia/reperfusion injury with nitroxyl donors

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  24. US 8258263

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.